Although previously classified in the clinical context of SCA under the designation SCA25, heterozygous pathogenic variants in the PNPT1 gene may result in a very early-onset neurological presentation of spastic ataxia with significant neuro-ophthalmological involvement, as described in our case report. The gene discussed is PNPT1; the disease is spastic ataxia.